Literature DB >> 8557446

Do cardiovascular disease risk factors predict all-cause mortality?

A Norrish1, D North, R L Yee, R Jackson.   

Abstract

BACKGROUND: The purpose of this study is to describe associations between a number of standard cardiovascular risk factors and all-cause mortality.
METHOD: Mortality data were collected for a randomly selected cohort of 1029 New Zealand men aged 35-64 years, followed up over a 9-year period. A proportional hazards regression model was used to estimate the relative risks (RR) for all-cause mortality associated with a number of cardiovascular risk factors.
RESULTS: In all, 96 deaths occurred over the 9-year period, of which 50% were due to cardiovascular causes. All-cause mortality was positively associated with cigarette smoking (age-adjusted RR = 2.01, 95% CI:1.15-3.53, current versus never), systolic blood pressure (age-adjusted RR = 2.18, 95% CI:1.23-4.44, upper versus lower tertile), and body mass index (age-adjusted RR = 1.59, 95% CI:0.94-2.66, upper versus lower tertile) and inversely associated with high density lipoprotein (HDL)-cholesterol (age-adjusted RR = 0.45, 95% CI:0.25-0.80, upper versus lower tertile). All-cause mortality was only weakly associated with serum total cholesterol (age-adjusted RR = 1.19, 95% CI:0.70-1.99, upper versus lower tertile), and there was no evidence of a U-shaped relationship for this risk factor. There was an inverse association between all-cause mortality and socioeconomic status (age-adjusted RR = 1.70, 95% CI:1.03-2.80, lower versus upper). Light alcohol consumption was associated with reduced all-cause mortality (age-adjusted RR = 0.63, 95% CI:0.37-1.05, light versus teetotal), but this benefit did not persist for alcohol consumption above about three standard drinks per day.
CONCLUSIONS: The findings of this study indicate that the standard cardiovascular risk factors are likely to have a beneficial impact on all-cause mortality as well as cardiovascular disease in middle-aged and older men.

Entities:  

Keywords:  Adult; Age Factors; Age Specific Death Rate; Alcohol Drinking; Behavior; Biology; Cardiovascular Effects; Cholesterol; Cohort Analysis; Death Rate; Demographic Factors; Developed Countries; Diseases; Follow-up Studies; Heart Diseases; Lipids; Middle Aged--men; Models, Theoretical; Mortality--men; New Zealand; Oceania; Physiology; Population; Population Characteristics; Population Dynamics; Research Methodology; Risk Factors; Smoking; Studies; Treatment

Mesh:

Substances:

Year:  1995        PMID: 8557446     DOI: 10.1093/ije/24.5.908

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  5 in total

1.  The Relationship between Very High Levels of Serum High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in a 20-Year Follow-Up Study of Japanese General Population.

Authors:  Aya Hirata; Tomonori Okamura; Daisuke Sugiyama; Kazuyo Kuwabara; Aya Kadota; Akira Fujiyoshi; Katsuyuki Miura; Nagako Okuda; Takayoshi Ohkubo; Akira Okayama; Hirotsugu Ueshima
Journal:  J Atheroscler Thromb       Date:  2016-02-26       Impact factor: 4.928

2.  A dose-response meta-analysis to evaluate the relationship between high-density lipoprotein cholesterol and all-cause and cardiovascular disease mortality.

Authors:  L Liu; M Han; R Qie; Q Li; X Zhang; J Zhang; S Zhan; L Zhang; Z Xu; C Zhang; F Hong
Journal:  J Endocrinol Invest       Date:  2021-10-21       Impact factor: 4.256

3.  The Best Predictors of Survival: Do They Vary by Age, Sex, and Race?

Authors:  Noreen Goldman; Dana A Glei; Maxine Weinstein
Journal:  Popul Dev Rev       Date:  2017-07-17

4.  Improving mortality prediction using biosocial surveys.

Authors:  Noreen Goldman; Dana A Glei; Yu-Hsuan Lin; Maxine Weinstein
Journal:  Am J Epidemiol       Date:  2009-01-15       Impact factor: 4.897

5.  BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants.

Authors:  Dagfinn Aune; Abhijit Sen; Manya Prasad; Teresa Norat; Imre Janszky; Serena Tonstad; Pål Romundstad; Lars J Vatten
Journal:  BMJ       Date:  2016-05-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.